October 25, 2021
Video
Booster dose eligibility is broadening as the flu season approaches. An expert emphasizes the need to protect for both COVID-19 and the flu in the coming months.
Article
Unpublished data from the company's ongoing pediatric trial show children aged 6 to
October 21, 2021
The FDA and CDC have authorized and recommended 3 different booster doses, to be used in "mix-and-match" strategy among eligible adults. What does this mean for immunity?
October 18, 2021
The decision comes after supporting data from a "mix and match" trial last week, and may align with emergency authorizations for the Moderna and Janssen booster doses.
October 12, 2021
People who inject drugs in rural areas had a less accurate understanding of HIV PrEP, largely due to stigma surrounding sexual orientation and drug use.
October 03, 2021
Monica McArthur, MD, PhD, discusses why to-be-authorized COVID-19 vaccine doses for children may not be tiered for patient risk as they were for adults.
October 02, 2021
The findings have supported the launch of a phase 3 trial called EVERGREEN, which is now underway.
September 30, 2021
In the primary efficacy analysis, the risk of developing symptomatic COVID 19 was reduced by 77% with AZD7442.
September 29, 2021
An expert explains the science of vaccine- and infection-induced immunity, and how it informs the timeline of COVID-19 outbreaks this year.
September 28, 2021
The companies will be seeking emergency authorization for a lighter-dose mRNA vaccine for children aged 5 to
